Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2681 |
|
| Actual shortage: | 255 (10%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2417 (90%) | |
Discontinuation Reports |
250 |
|
| To be discontinued: | 3 (1%) | |
| Discontinued: | 247 (99%) | |
| Reversed: | 0 (0%) | |
Late reports |
330 (11%) |
|
Overdue reports |
23 (9%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-CEPHALEXIN 125 | 125MG | POWDER FOR SUSPENSION | Resolved | 2024-01-25 | 2024-03-18 | 217220 |
| TEVA-CEPHALEXIN 250 | 250MG | POWDER FOR SUSPENSION | Actual shortage | 2024-02-29 | 2024-05-09 | 220977 |
| TEVA-CEPHALEXIN 250 | 250MG | POWDER FOR SUSPENSION | Actual shortage | 2024-05-09 | 2024-05-09 | 227459 |
| OCTREOTIDE FOR INJECTABLE SUSPENSION | 10MG | POWDER FOR SUSPENSION, EXTENDED-RELEASE KIT | Resolved | 2022-03-04 | 2022-03-24 | 156070 |
| OCTREOTIDE FOR INJECTABLE SUSPENSION | 10MG | POWDER FOR SUSPENSION, SUSTAINED-RELEASE KIT | Actual shortage | 2022-08-18 | 2024-05-16 | 166969 |
| OCTREOTIDE FOR INJECTABLE SUSPENSION | 20MG | POWDER FOR SUSPENSION, SUSTAINED-RELEASE KIT | Actual shortage | 2022-08-18 | 2024-05-16 | 166972 |
| OCTREOTIDE FOR INJECTABLE SUSPENSION | 30MG | POWDER FOR SUSPENSION, SUSTAINED-RELEASE KIT | Actual shortage | 2022-08-18 | 2024-05-16 | 166975 |
| TEVA-TRAVOPROST Z OPHTHALMIC SOLUTION | 0.004% | SOLUTION | Resolved | 2017-03-13 | 2020-01-21 | 1659 |
| TEVA-TRAVOPROST Z OPHTHALMIC SOLUTION | 0.004% | SOLUTION | Resolved | 2017-03-13 | 2020-01-21 | 1664 |
| DOCETAXEL INJECTION | 20MG | SOLUTION | Actual shortage | 2017-03-13 | 2017-10-05 | 1680 |
| DOCETAXEL INJECTION | 80MG | SOLUTION | Actual shortage | 2017-03-13 | 2017-10-05 | 1688 |
| EPTIFIBATIDE INJECTION | 0.75MG | SOLUTION | Resolved | 2017-03-13 | 2020-02-13 | 1691 |
| EPTIFIBATIDE INJECTION | 2MG | SOLUTION | Resolved | 2017-03-13 | 2020-02-13 | 1694 |
| LINEZOLID INJECTION | 2MG | SOLUTION | Resolved | 2017-03-13 | 2020-02-13 | 1711 |
| ONDANSETRON INJECTION | 2MG | SOLUTION | Actual shortage | 2017-03-13 | 2017-10-05 | 1746 |
| ONDANSETRON INJECTION | 2MG | SOLUTION | Actual shortage | 2017-03-13 | 2017-10-05 | 1754 |
| RATIO-SALBUTAMOL | 0.5MG | SOLUTION | Resolved | 2017-03-14 | 2020-02-13 | 2419 |
| METHOTREXATE SODIUM INJECTION | 25MG | SOLUTION | Resolved | 2017-03-17 | 2017-05-10 | 3115 |
| RATIO-IPRA SAL UDV | 0.5MG 2.5MG | SOLUTION | Resolved | 2017-03-17 | 2017-07-28 | 3137 |
| TEVA-IPRATROPIUM STERINEBS | 0.025% | SOLUTION | Resolved | 2017-04-25 | 2017-10-10 | 8071 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| ACT OXYCODONE CR | 80MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63992 |
| ACT OXYCODONE CR | 5MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-22 | 2018-10-22 | 65328 |
| ACT DONEPEZIL ODT | 10MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2018-10-19 | 2018-10-19 | 64872 |
| ACT DONEPEZIL ODT | 5MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2018-10-19 | 2018-10-19 | 64875 |
| ACT OLANZAPINE ODT | 5MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2019-10-25 | 2019-10-26 | 97256 |
| ACT OLANZAPINE ODT | 15MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2020-01-24 | 2020-01-24 | 104277 |
| TEVA-DEFERASIROX | 500MG | TABLET FOR SUSPENSION | Discontinued | 2019-10-25 | 2019-10-26 | 97248 |
| TEVA-DEFERASIROX | 500MG | TABLET FOR SUSPENSION | Discontinued | 2019-10-31 | 2019-11-01 | 97589 |
| TEVA-DEFERASIROX | 125MG | TABLET FOR SUSPENSION | Discontinued | 2020-01-21 | 2020-01-21 | 103791 |
| TEVA-DEFERASIROX | 250MG | TABLET FOR SUSPENSION | Discontinued | 2020-01-21 | 2020-01-21 | 103796 |